Adarigiline
Jump to navigation
Jump to search
| File:Adarigiline.svg | |
| Clinical data | |
|---|---|
| Drug class | Monoamine oxidase B (MAO-B) inhibitor |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| E number | {{#property:P628}} |
| CompTox Dashboard (EPA) |
|
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C15H15F3N2O3S |
| Molar mass | 360.35 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Adarigiline (INN) is a monoamine oxidase inhibitor (MAOI) that was never marketed.[1][2][3][4] It is specifically a monoamine oxidase B (MAO-B) inhibitor.[1][2][3] This drug candidate was first described in 2009, in a patent assigned to Helicon Therapeutics.[5]
References
[edit | edit source]- ^ a b Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ a b Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ a b Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ WO 2009/029632A1, Kaplan AP, Keenan TP, Mcriner AJ, "Therapeutic isoxazole compounds", published Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value)., assigned to Helicon Therapeutics, Inc.
 | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |